# AdaptHealth Corp. (AHCO) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Technology. Price $6.49, market value $866 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). AdaptHealth Corp. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 0.3×**. Each dollar of revenue is priced at 0.3×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 0.6×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **EV / EBITDA: 9.4×**. Enterprise value is 9.4× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 11.3%** (5-yr avg 10.2%). Free cash flow equals 11.3% of the market value, in line with its five-year average of 10.2%. Above 5% is generally attractive.

## Profitability
- **Operating margin: -4.5%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -2.2%**. The company reported a net loss over the last twelve months.
- **Return on equity: -4.7%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -3.5%**. Return on all capital, debt included, is -3.5%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -5.3%**. Each dollar of assets produces -5.3% of profit.

## Growth
- **Revenue growth (1 yr): -0.5%** (3-yr 3.0%/yr, 5-yr 25.2%/yr). Revenue fell 0.5% over the last year, against 25.2% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -185.2%**. Earnings per share fell 185.2%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 1.14**. Debt is 1.14 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Current ratio: 1.02** (quick 1.02). Current assets cover the next year's liabilities 1.02 times.
- **Altman Z-score: 1.50**. A Z-score of 1.50 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. AdaptHealth Corp. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (7 analysts). 7 analysts cover AdaptHealth Corp.; the consensus is strong_buy, with an average price target of $9.14 (+41% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -29.5%** (YTD -34.8%, 3-mo -34.4%). The shares are down 29.5% over twelve months including dividends.
- **From 52-week high: -51.7%** (24.6% above the low). Trading 52% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 47**. An RSI of 47 is neutral.
- **Beta (1 yr): 0.04** (volatility 62%). Beta of 0.04 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=AHCO · Page: https://foliofundamentals.com/stocks/ahco

Not investment advice.